CORE LABORATORIES INC. (CLB) EBITDA
- 2026-06-30: Basis Reported; EBITDA $12.98M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA $5.65M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $19.5M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA $24.52M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2021-12-31 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | $12.98M | (m) | (m) | (m) | 10.41% | $4.69M* | $7.81M* | $101.37M | (m) | (m) | $507.00K |
|---|
| 2026-03-31 | Reported | $5.65M | (m) | (m) | (m) | 4.64% | $3.45M | $3.96M | $102.07M | (m) | (m) | -$251.00K |
|---|
| 2025-12-31 | Reported | $19.5M | (m) | (m) | (m) | 14.10% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | $24.52M | (m) | (m) | (m) | 18.23% | $2.01M* | $8.50M* | $104.90M | (m) | (m) | $3.75M |
|---|
| 2025-06-30 | Reported | $18.96M | (m) | (m) | (m) | 14.57% | $3.47M* | $13.92M* | $103.70M | (m) | (m) | $1.91M |
|---|
| 2025-03-31 | Reported | $8.13M | (m) | (m) | (m) | 6.58% | $2.79M | $6.66M | $99.47M | (m) | (m) | $1.75M |
|---|
| 2024-12-31 | Reported | $17.84M | (m) | (m) | (m) | 13.80% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | $23.48M | (m) | (m) | (m) | 17.47% | $2.73M* | $13.10M* | $106.81M | (m) | (m) | $4.69M |
|---|
| 2024-06-30 | Reported | $19.78M | (m) | (m) | (m) | 15.15% | $2.87M* | $17.15M* | $102.93M | (m) | (m) | $3.61M |
|---|
| 2024-03-31 | Reported | $12.41M | (m) | (m) | (m) | 9.58% | $3.05M | $5.53M | $104.59M | (m) | (m) | $1.66M |
|---|
| 2023-12-31 | Reported | $18.46M | (m) | (m) | (m) | 14.39% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | $18.6M | (m) | (m) | (m) | 14.84% | $3.46M | -$212.00K* | (m) | (m) | (m) | $2.31M |
|---|
| 2023-06-30 | Reported | $22.84M | (m) | (m) | (m) | 17.86% | $2.17M | $8.74M* | (m) | (m) | (m) | -$7.26M |
|---|
| 2023-03-31 | Reported | $10.53M | (m) | (m) | (m) | 8.20% | $2.21M | -$3.17M | (m) | (m) | (m) | $610.00K |
|---|
| 2022-12-31 | Reported | $19.69M | (m) | (m) | (m) | 15.44% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | $18.82M | (m) | (m) | (m) | 14.94% | $2.70M | $5.85M* | (m) | (m) | (m) | $3.86M |
|---|
| 2022-06-30 | Reported | $16.01M | (m) | (m) | (m) | 13.24% | $3.20M | (m) | (m) | (m) | (m) | $1.79M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $71.12M | (m) | (m) | (m) | 13.51% | $11.21M | $37.03M | $417.59M | (m) | (m) | $15.51M |
|---|
| 2024-12-31 | Reported | $73.51M | (m) | (m) | (m) | 14.03% | $11.89M | $56.39M | $420.52M | (m) | (m) | $14.03M |
|---|
| 2023-12-31 | Reported | $70.42M | (m) | (m) | (m) | 13.81% | $10.58M | $24.79M | $399.96M | (m) | (m) | $4.18M |
|---|
| 2022-12-31 | Reported | $58.69M | (m) | (m) | (m) | 11.98% | $10.22M | $24.96M | $393.65M | (m) | (m) | $10.30M |
|---|
| 2021-12-31 | Reported | $63.78M | (m) | (m) | (m) | 13.56% | $13.54M | $36.58M | (m) | (m) | (m) | $15.89M |
|---|